As can be seen from Part 2, there are a number of other situations where timely access to safe and effective medicines is important—other pandemic vaccines, medicines where a class is affected by supply shortages and alternatives are needed rapidly. I would also note that the Therapeutic Products Bill, which the Ministry of Health is currently working on ahead of introduction to Parliament next year, will repeal and replace the Medicines Act and address wider issues with its relevance and application. The amendment today brings forward some of those planned changes.